Tim A. Labeur

537 total citations
17 papers, 247 citations indexed

About

Tim A. Labeur is a scholar working on Hepatology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tim A. Labeur has authored 17 papers receiving a total of 247 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hepatology, 11 papers in Surgery and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tim A. Labeur's work include Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers) and Gallbladder and Bile Duct Disorders (5 papers). Tim A. Labeur is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers) and Gallbladder and Bile Duct Disorders (5 papers). Tim A. Labeur collaborates with scholars based in Netherlands, Germany and United Kingdom. Tim A. Labeur's co-authors include Heinz‐Josef Klümpen, Otto M. van Delden, R. Bart Takkenberg, Jeroen L.A. van Vugt, Jan N.M. IJzermans, Bas Groot Koerkamp, Thomas M. van Gulik, Marcia P. Gaspersz, Robert A. de Man and Ferry A.L.M. Eskens and has published in prestigious journals such as Journal of Hepatology, Clinical Gastroenterology and Hepatology and Annals of Surgical Oncology.

In The Last Decade

Tim A. Labeur

17 papers receiving 247 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tim A. Labeur Netherlands 11 126 111 84 83 68 17 247
Andrea Fontana Italy 11 130 1.0× 180 1.6× 136 1.6× 137 1.7× 35 0.5× 25 322
Michinori Hamaoka Japan 10 190 1.5× 77 0.7× 136 1.6× 55 0.7× 76 1.1× 38 283
Songqiang Zhou China 9 178 1.4× 74 0.7× 107 1.3× 82 1.0× 69 1.0× 15 294
Hideya Suga Japan 8 144 1.1× 98 0.9× 93 1.1× 62 0.7× 57 0.8× 24 257
Yasuhiro Yabushita Japan 10 54 0.4× 155 1.4× 170 2.0× 114 1.4× 43 0.6× 41 290
Hajime Aino Japan 9 211 1.7× 110 1.0× 64 0.8× 50 0.6× 99 1.5× 10 320
Elena Panettieri Italy 8 160 1.3× 142 1.3× 168 2.0× 113 1.4× 19 0.3× 45 283
Ann Tan United States 7 70 0.6× 95 0.9× 98 1.2× 61 0.7× 53 0.8× 16 235
Satheesh Chiradoni Thungappa India 4 201 1.6× 42 0.4× 174 2.1× 71 0.9× 67 1.0× 13 305
Qinglong Jiang China 11 45 0.4× 121 1.1× 173 2.1× 120 1.4× 38 0.6× 16 247

Countries citing papers authored by Tim A. Labeur

Since Specialization
Citations

This map shows the geographic impact of Tim A. Labeur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim A. Labeur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim A. Labeur more than expected).

Fields of papers citing papers by Tim A. Labeur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim A. Labeur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim A. Labeur. The network helps show where Tim A. Labeur may publish in the future.

Co-authorship network of co-authors of Tim A. Labeur

This figure shows the co-authorship network connecting the top 25 collaborators of Tim A. Labeur. A scholar is included among the top collaborators of Tim A. Labeur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim A. Labeur. Tim A. Labeur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Burgmans, Mark C., Daphne D. D. Rietbergen, Minneke J. Coenraad, et al.. (2021). Liver Decompensation as Late Complication in HCC Patients with Long-Term Response following Selective Internal Radiation Therapy. Cancers. 13(21). 5427–5427. 5 indexed citations
2.
Gaspersz, Marcia P., Eva Roos, Lotte C. Franken, et al.. (2020). Eligibility for Liver Transplantation in Patients with Perihilar Cholangiocarcinoma. Annals of Surgical Oncology. 28(3). 1483–1492. 19 indexed citations
3.
Gaspersz, Marcia P., Eva Roos, Lotte C. Franken, et al.. (2020). Eligibility for liver transplantation in patients with perihilar cholangiocarcinoma. European Journal of Surgical Oncology. 46(2). e27–e27. 2 indexed citations
4.
Labeur, Tim A., R. Bart Takkenberg, Otto M. van Delden, et al.. (2020). The value of sorafenib trough levels in patients with advanced hepatocellular carcinoma – a substudy of the SORAMIC trial. Acta Oncologica. 59(9). 1028–1035. 11 indexed citations
5.
Labeur, Tim A., Kasia P. Cieslak, Thomas M. van Gulik, et al.. (2020). The utility of 99mTc-mebrofenin hepatobiliary scintigraphy with SPECT/CT for selective internal radiation therapy in hepatocellular carcinoma. Nuclear Medicine Communications. 41(8). 740–749. 11 indexed citations
6.
Braat, Manon N.G.J.A., Tim A. Labeur, Otto M. van Delden, et al.. (2019). A Pilot Study on Hepatobiliary Scintigraphy to Monitor Regional Liver Function in 90Y Radioembolization. Journal of Nuclear Medicine. 60(10). 1430–1436. 22 indexed citations
7.
Labeur, Tim A., Jurgen H. Runge, Elisabeth G. Klompenhouwer, et al.. (2019). Diffusion-weighted imaging of hepatocellular carcinoma before and after transarterial chemoembolization: role in survival prediction and response evaluation. Abdominal Radiology. 44(8). 2740–2750. 15 indexed citations
8.
Labeur, Tim A., Frederike Dijk, Martijn G.H. van Oijen, et al.. (2019). Prognostic immunohistochemical biomarkers of chemotherapy efficacy in biliary tract cancer: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology. 141. 82–94. 8 indexed citations
9.
Labeur, Tim A., Sarah Berhane, Julien Edeline, et al.. (2019). Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib. Liver International. 40(1). 215–228. 28 indexed citations
10.
Labeur, Tim A., et al.. (2019). Sorafenib for Patients with Hepatocellular Carcinoma and Child-Pugh B Liver Cirrhosis: Lessons Learned from a Terminated Study. The Oncologist. 25(9). e1274–e1279. 12 indexed citations
11.
Labeur, Tim A., Jeroen L.A. van Vugt, David W.G. ten Cate, et al.. (2018). Body Composition Is an Independent Predictor of Outcome in Patients with Hepatocellular Carcinoma Treated with Sorafenib. Liver Cancer. 8(4). 255–270. 29 indexed citations
12.
Labeur, Tim A., R. Bart Takkenberg, Heinz‐Josef Klümpen, & Otto M. van Delden. (2018). Reason of Discontinuation After Transarterial Chemoembolization Influences Survival in Patients with Hepatocellular Carcinoma. CardioVascular and Interventional Radiology. 42(2). 230–238. 12 indexed citations
13.
Labeur, Tim A., David W.G. ten Cate, R. Bart Takkenberg, et al.. (2018). Are we SHARP enough? The importance of adequate patient selection in sorafenib treatment for hepatocellular carcinoma. Acta Oncologica. 57(11). 1467–1474. 10 indexed citations
14.
Gaspersz, Marcia P., Robert J.S. Coelen, Tim A. Labeur, et al.. (2017). The prognostic value of hepatic arterial and portal venous involvement in patients with perihilar cholangiocarcinoma. HPB. 19. S47–S47. 1 indexed citations
15.
Vugt, Jeroen L.A. van, Marcia P. Gaspersz, Robert J.S. Coelen, et al.. (2017). The prognostic value of portal vein and hepatic artery involvement in patients with perihilar cholangiocarcinoma. HPB. 20(1). 83–92. 48 indexed citations
16.
Coelen, Robert J.S., Marcia P. Gaspersz, Tim A. Labeur, et al.. (2017). Validation of the Mayo Clinic Staging System in Determining Prognoses of Patients With Perihilar Cholangiocarcinoma. Clinical Gastroenterology and Hepatology. 15(12). 1930–1939.e3. 13 indexed citations
17.
Gaspersz, Marcia P., Robert J.S. Coelen, Tim A. Labeur, et al.. (2017). The prognostic value of hepatic artery and portal vein involvement in patients with perihilar cholangiocarcinoma. Journal of Hepatology. 66(1). S447–S447. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea Fontana Breakdown of academic impact, for papers by Michinori Hamaoka Breakdown of academic impact, for papers by Songqiang Zhou Breakdown of academic impact, for papers by Hideya Suga Breakdown of academic impact, for papers by Yasuhiro Yabushita Breakdown of academic impact, for papers by Hajime Aino Breakdown of academic impact, for papers by Elena Panettieri Breakdown of academic impact, for papers by Ann Tan Breakdown of academic impact, for papers by Satheesh Chiradoni Thungappa Breakdown of academic impact, for papers by Qinglong Jiang
Rankless by CCL
2026